Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren alone or with ramipril in hypertension and diabetes
2004-001062-40Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) and diabetes mellitus (DM) comparing Aliskiren monotherapy, Ramipril monotherapy and Aliskiren + ramipril combination (3 arms). Primary endpoint: Change from baseline in mean sitting diastolic blood pressure. Started Oct 2004; status: completed.
02
Drugs
aliskirenramipril
03
Conditions
hypertension (HTN)diabetes mellitus (DM)
Beyond the preview
Go deeper on 2004-001062-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001062-40.